MHC-Peptide Complex: Central Hub of Immune Response and Core Mechanism of Antigen Presentation

Author: Senior Product Manager of UA Views：755

The innate immune system establishes a multi-layered antigen-monitoring network to counter persistent pathogenic microbial threats. In contrast, the adaptive immune system demonstrates more sophisticated regulatory sophistication: when specific B cells or T cells encounter no cognate antigens during their lifespan, their immune receptors remain in a state of functional dormancy.

Recent Advances
Product Information

Recent Advances

MHC Peptide Complexes

The natural immune system has established a multi - level antigen surveillance network to combat continuous pathogen threats. The adaptive immune system shows more refined regulation: B or T cells remain inactive until they encounter matching antigens. This on - demand activation ensures efficient immune responses—only lymphocytes with pathogen - specific receptors (TCR/BCR) are activated.

This article focuses on T cell activation regulation and its dynamic interaction with MHC - peptide complexes.

T Cell Receptor (TCR)

T cells express two unique TCRs: αβ TCR and γδ TCR. Both are composed of two polypeptide chains linked by disulfide bonds. αβ TCR comprises α - and β - chains, while γδ TCR comprises γ - and δ - chains. Similar to BCR diversity from V(D)J gene rearrangement, TCR chains (α, β, γ, δ) undergo somatic recombination of V, D, and J gene segments. This ensures each T cell expresses only one TCR type (αβ or γδ).

About 95% of mature T cells express αβ TCR, and 5% express γδ TCR. Most αβ T cells co - express CD4 or CD8 co - receptors. CD4 aids helper T cells (Th) in recognizing MHC II molecules, and CD8 facilitates cytotoxic T lymphocytes (CTL) in binding to MHC I molecules. In contrast, γδ T cells express neither CD4 nor CD8, forming a unique phenotype.

In the thymus, αβ T cells undergo stringent selection: positive selection for MHC - restricted recognition and negative selection for self - tolerance. However, γδ T cell development is less understood. Although the thymus is their developmental site, athymic nude mice can still produce functional γδ T cells, suggesting extrathymic development pathways. γδ TCR, like BCR, can recognize non - peptide antigens, but its exact antigen spectrum is unclear, implying γδ T cells may act as "non - traditional antigen detectors" in immune surveillance.

The biological functions of αβ T cells are well - understood. αβ TCR recognizes cell - surface MHC - peptide complexes. This complex consists of antigenic peptides in the MHC binding groove and MHC molecules. TCR has dual specificity — recognizing antigenic peptide sequences and MHC allele types. This gives T cells strict MHC restriction: human T cells only recognize peptides bound to self - HLA I or II molecules.

T Cell Signaling

After TCR recognizes MHC - presented antigen, the signal is transmitted across the membrane to the nucleus. Like BCR signaling, TCR complexes use transmembrane proteins for signal transduction. The extracellular domain recognizes antigens, and the intracellular domain initiates cascading signals. However, unlike BCR's complete signaling unit, αβ TCR's α - and β - chains have short cytoplasmic tails (3 - 5 amino acids) and can't transduce signals alone.

To overcome this, TCR forms a functional unit with the CD3 complex. This complex consists of γ, δ, ε, and ζ chains, each with extracellular, transmembrane, and intracellular signaling regions. This modular assembly ensures the TCR - CD3 complex reaches the cell membrane as a complete hexamer (αβ - γδεζ). Any defect in subunit expression leads to non - functional TCR.

CD3 plays a key signaling role through its cytoplasmic tail with immune receptor tyrosine - based activation motifs (ITAMs). When TCR binds the antigenic peptide - MHC complex, CD3 undergoes conformational changes. ITAMs are phosphorylated, recruiting and activating kinases like ZAP - 70 to form a signaling complex. This convergent evolution with BCR's BCAP system amplifies signals through kinase recruitment upon receptor aggregation.

Early views of TCR as a binary switch have evolved with the discovery of CD3 - mediated multi - dimensional signaling. In the thymus, TCR recognition of self - peptide - MHC complexes can trigger apoptosis via caspase activation to establish central tolerance. In peripheral immune responses, TCR antigen recognition without co - stimulation (e.g., CD28) recruits E3 ubiquitin ligase Cbl - b, leading to T cell anergy. This context - dependent signaling enables the same TCR complex to produce diverse effects like survival, apoptosis, or inhibition.

MHC Peptide Complexes

The Major Histocompatibility Complex (MHC) is a group of highly polymorphic genes in the vertebrate genome. Their products, as cell - surface glycoproteins, are central to antigen presentation. By forming and displaying antigenic peptide - MHC complexes, MHC molecules initiate and regulate adaptive immune responses.

MHC Class I Molecules

MHC class I molecules are broadly expressed on almost all nucleated cells. They consist of a heavy α - chain and a light β₂ - microglobulin chain linked non - covalently. Their main function is to present endogenous antigenic peptides to CD8⁺ cytotoxic T lymphocytes (CTLs). These peptides mainly come from ubiquitin - proteasome - degraded endogenous proteins. During intracellular pathogen infection or malignant transformation, MHC I - antigenic peptide complexes activate CTLs for immune surveillance and clearance.

MHC Class II Molecules

MHC class II molecules are strictly expressed on professional antigen - presenting cells (APCs), such as dendritic cells, macrophages, and B lymphocytes. Their heterodimeric structure comprises α - and β - chains linked by disulfide bonds. They specialize in presenting exogenous antigenic peptides, which come from pathogen proteins hydrolyzed in phagosomes or endosomes. By displaying these peptides, MHC class II molecules activate CD4⁺ T helper cells (Th), regulating immune效应 mechanisms like antibody production, macrophage activation, and cytokine network formation.

Antigen Binding and Presentation Mechanism

MHC molecules bind antigenic peptides with dual specificity: recognizing specific anchor amino acid residues and fitting the binding groove formed by MHC polymorphic sites. This ensures the immune system recognizes diverse antigens while maintaining self - tolerance. The formed MHC - antigenic peptide complexes are stably expressed on the cell membrane via conformational locking, providing specific recognition targets for TCRs. This precisely conveys antigen information to T cell clones, triggering cascading immune responses. As the link between innate and adaptive immunity, MHC dynamically regulates antigen presentation, ensuring precise immune responses and enabling adaptability to diverse threats.

Related Products:

Disease Category	Product Name	Antigen	Sequence	MHC	Position	Product Number
EBV	HLA-A*0201/YLELLVWRL-PE Labelled Tetramer	EBV.LMP1	YLELLVWRL	HLA-A*0201	125-133	UA089001
EBV	HLA-A*0201/YLQQNWTL-PE Labelled Tetramer	EBV.LMP1	YLQQNWTL	HLA-A*0201	159-167	UA089003
EBV	H-2Db(b)/RAHY-NIVTF-PE Labelled Tetramer	HPV16.E7	RAHYNIVTF	H-2Db	49-57	UA089002
HPV	H-2K(b)/EVYDFA-FRQL-PE Labelled Tetramer	HPV16.E6	EVYDFARDL	H-2Kb	48-57	UA089004
HPV	HLA-A*0201/KLP-DLCTL-PE Labelled Tetramer	HPV18.E6	KLPDCTL	HLA-A*0201	13-21	UA089005
HPV	HLA-A*0201/KLTNT-GLYQL-PE Labelled Tetramer	HPV18.E6	KLTNTGLYNL	HLA-A*0201	92-101	UA089006
HPV	HLA-A*0201/TLODIVIHL-PE Labelled Tetramer	HPV18.E7	TLODIVIHL	HLA-A*0201	7~15	UA089007
HPV	HLA-A*0201/QFLNTL-FV-PE Labelled Tetramer	HPV18.E7	QFLNTLFSV	HLA-A*0201	88-97	UA089008
HPV	HLA-A*1101/GVNHQLPAR-PE Labelled Tetramer	HPV18.E7	GVNHQLPAR	HLA-A*1101	43-52	UA089009
Influenza A Virus	H-2D(b)/ASNENMETM-PE Labelled Tetramer	Flu.NP	ASNENMETM	H-2Db	366-374	UA089010
Influenza A Virus	H-2K(d)/TYQR-TRALY-PE Labelled Tetramer	Flu.NP	TYQRTRALY	H-2Kd	147-155	UA089011
Influenza A Virus	H-2D(b)/ASNEN-MDTM-PE Labelled Tetramer	Flu.NP	ASNENMDTM	H-2Db	366-374	UA089012
LCMV	H-2D(b)/KAVYNFATM-PE Labelled Tetramer	GP 33	KAVYNFATM	H-2Db	33-41	UA089013
LCMV	H-2D(b)/FQPGQGFVK-PE Labelled Tetramer	LCMV NP	FQPGQGFVK	H-2Db	396-404	UA089014
Tumor-related	HLA-A*1101/VVGADGVK-PE Labelled Tetramer	KRAS	VVGADGVK	HLA-A*1101	7~16	UA089015
Tumor-related	HLA-A*1101/VVGAGVGK-PE Labelled Tetramer	KRAS	VVGAGVGK	HLA-A*1101	7~16	UA089016
Tumor-related	HLA-A*0201/KLVVGAGV-PE Labelled Tetramer	KRAS	KLVVGAGV	HLA-A*0201	5~14	UA089017
Tumor-related	HLA-A*0201/SLLMWITQC-PE Labelled Tetramer	NY-ESO1	SLLMWITQC	HLA-A*0201	157-165	UA089018
Melanoma	HLA-A*0201/LMWITQCFL-PE Labelled Tetramer	NY-ESO2	LMWITQCFL	HLA-A*0201	159-167	UA089019
Melanoma	H-2Db(b)/MMFPNA-P1-PE Labelled Tetramer	WT1	RMFPNAPL	H-2Db	126-134	UA089020
Melanoma	HLA-A*0201/CMTWV-PE Labelled Tetramer	WT2	CMTWVNMDM	HLA-A*0201	235-243	UA089021
Melanoma	HLA-A*1101/KTCQRKSF-PE Labelled Tetramer	WT3	KTCQRKSF	HLA-A*1101	386-394	UA089022
Ovarian Cancer	H-2K(b)/SINFEKL-PE Labelled Tetramer	OVA	SINFEKL	H-2Kb	257-264	UA089023

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next